...
机译:IL-2疗法优先扩展养护的供体特异性Tregs改善皮肤同种异体移植物生存期
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
Department of Inflammation BiologyMRC Centre for TransplantationLondon UK;
Department of Inflammation BiologyMRC Centre for TransplantationLondon UK;
MRC Centre for TransplantationFaculty of Life Sciences &
MedicineLondon UK;
antigen presentation/recognition; basic (laboratory) research/science; graft survival; immune regulation; immunobiology; immunosuppression/immune modulation; organ transplantation in general; T cell biology; tolerance; translational research/science;
机译:IL-2疗法优先扩展养护的供体特异性Tregs改善皮肤同种异体移植物生存期
机译:Eomesodermin在癌症免疫疗法的养态转移模型中增加肿瘤特异性CD8(+)T细胞的存活率和IL-2反应性
机译:离体扩增人CD1(9)+ TIM-1(+)B调节细胞可以延长人源化的皮肤移植的人源化的小鼠模型中的人同种异体移植,并可诱导人CD4(+)CD25(+)CD127(LO)Treg
机译:永久性心脏异种移植生存期亚替代链霉抗生物素蛋白疗法的优化
机译:增强过继性T细胞转移疗法:通过IL-12 CD8 T细胞启动和组蛋白脱乙酰基酶抑制剂的辅助使用的新疗法
机译:IL-2治疗优先扩大过继转移的供体特异性Treg从而改善同种异体皮肤存活
机译:使用扩大的黑色素瘤特异性T细胞编程过活的过继转移疗法以提高体内功效